Guanfacine intoxication in a young child presenting with prolonged somnolence and sinus bradycardia: a case report

Guanfacine, a medication used to treat attention deficit hyperactivity disorder (ADHD), activates alpha-2A adrenergic receptors in the brain to reduce symptoms. However, its central alpha-2 agonist activity can cause adverse events, such as somnolence, bradycardia, and hypotension. We present the case of a 6-year-old boy (15 kg) with no history of regular medication use who was admitted to the hospital with unexplained prolonged somnolence and bradycardia. Initial evaluation ruled out common causes; however, ingestion of his mother's prescription medication was suspected. Liquid chromatography-quadrupole time-of-flight mass spectrometry confirmed the presence of 6 ng/mL of guanfacine in his serum, which, together with his symptoms, led to a diagnosis of guanfacine intoxication. To our knowledge, this is the first report of guanfacine intoxication in a young child without ADHD with documented serum concentration measurements. This case may help in the recognition and diagnosis of guanfacine toxicity in pediatric patients.

Authors

Institutions

Publication Details

Journal
Journal of Analytical Toxicology
Published
2025-08-20
DOI
https://doi.org/10.1093/jat/bkaf080
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Guanfacine intoxication in a young child presenting with prolonged somnolence and sinus bradycardia: a case report

Hiroshi Okada, Sayaka Nagasawa, Go Inokuchi, Hirotaro Iwase et al.
Journal of Analytical Toxicology
Attention Deficit Hyperactivity Disorder
article

Guanfacine intoxication in a young child presenting with prolonged somnolence and sinus bradycardia: a case report

Hiroshi Okada, Sayaka Nagasawa, Go Inokuchi, Hirotaro Iwase, Minami Daikai
article en

Abstract

Guanfacine, a medication used to treat attention deficit hyperactivity disorder (ADHD), activates alpha-2A adrenergic receptors in the brain to reduce symptoms. However, its central alpha-2 agonist activity can cause adverse events, such as somnolence, bradycardia, and hypotension. We present the case of a 6-year-old boy (15 kg) with no history of regular medication use who was admitted to the hospital with unexplained prolonged somnolence and bradycardia. Initial evaluation ruled out common causes; however, ingestion of his mother's prescription medication was suspected. Liquid chromatography-quadrupole time-of-flight mass spectrometry confirmed the presence of 6 ng/mL of guanfacine in his serum, which, together with his symptoms, led to a diagnosis of guanfacine intoxication. To our knowledge, this is the first report of guanfacine intoxication in a young child without ADHD with documented serum concentration measurements. This case may help in the recognition and diagnosis of guanfacine toxicity in pediatric patients.

Journal of Analytical Toxicology
Chiba University (JP), Matsudo City Hospital (JP)
Openalex Percentile: Top 74%
Attention Deficit Hyperactivity Disorder
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Guanfacine intoxication in a young child presenting with prolonged somnolence and sinus bradycardia: a case report — Hiroshi Okada, Sayaka Nagasawa, et al. · Journal of Analytical Toxicology (2025) | TGRS Research Map | TGRS